Gut Liver.
2016 Mar;10(2):162-163. 10.5009/gnl16024.
Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis
- Affiliations
-
- 1Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea. geniushee@yuhs.ac
- KMID: 2363960
- DOI: http://doi.org/10.5009/gnl16024
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Reversible Corpus Callosal Lesions Associated with the Use of Adalimumab for Ulcerative Colitis
- Efficacy and Safety of Adalimumab in Moderately to Severely Active Cases of Ulcerative Colitis: A Meta-Analysis of Published Placebo-Controlled Trials
- Treatment of Recalcitrant Pyoderma Gangrenosum with Ulcerative Colitis by Adalimumab Injection
- Golimumab Therapy in Ulcerative Colitis
- Biologics for the treatment of pyoderma gangrenosum in ulcerative colitis
